Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$1.6 million.

  • Firefly Neuroscience's Net Cash Flow fell 28268.35% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year increase of 81839.76%. This contributed to the annual value of -$333000.0 for FY2024, which is 11597.12% down from last year.
  • Latest data reveals that Firefly Neuroscience reported Net Cash Flow of -$1.6 million as of Q3 2025, which was down 28268.35% from -$3.6 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Net Cash Flow registered a high of $7.7 million during Q1 2025, and its lowest value of -$3.6 million during Q2 2025.
  • Its 5-year average for Net Cash Flow is $77326.7, with a median of $83641.0 in 2023.
  • Its Net Cash Flow has fluctuated over the past 5 years, first tumbled by 70377.09% in 2024, then skyrocketed by 163168.32% in 2025.
  • Over the past 5 years, Firefly Neuroscience's Net Cash Flow (Quarter) stood at $1.2 million in 2021, then plummeted by 297.11% to -$2.5 million in 2022, then soared by 150.79% to $1.2 million in 2023, then tumbled by 53.6% to $580000.0 in 2024, then crashed by 374.66% to -$1.6 million in 2025.
  • Its Net Cash Flow stands at -$1.6 million for Q3 2025, versus -$3.6 million for Q2 2025 and $7.7 million for Q1 2025.